Glenmark launches TEVIMBRA in India for treatment of advanced lung and oesophageal cancer EP News Bureau Jun 24, 2025 Glenmark Pharmaceuticals introduces tislelizumab following CDSCO approval, expanding its oncology portfolio with its first…
